COMPANY
GLEAMER
Healthcare technology company based in Paris, France
Founded 2017Paris, France
Gleamer expands into MRI with acquisitions of Pixyl and Caerus Medical
Following the recent launch of BreastView, its CE-marked AI application for breast cancer detection, Gleamer is further expanding its product portfolio with the acquisition of Pixyl and Caerus Medical.
Pixyl.Neuro leverages AI for detecting abnormalities in brain MRI scans, while Caerus Medical’s LumbAI supports the diagnosis of lumbar pathologies.
With these additions, Gleamer now offers AI solutions across all core imaging modalities, including x-ray, mammography, CT, and MRI.
